Related references
Note: Only part of the references are listed.Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient
D. Jacobs-Tulleneers-Thevissen et al.
DIABETOLOGIA (2013)
Cell-Based Therapeutics: The Next Pillar of Medicine
Michael A. Fischbach et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Reprogrammed cell delivery for personalized medicine
Markus Wieland et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Building synthetic cell systems from the ground up
Hal Alper et al.
CURRENT OPINION IN BIOTECHNOLOGY (2012)
Discovery, design and synthesis of Y-shaped peroxisome proliferator-activated receptor δ agonists as potent anti-obesity agents in vivo
Jungyeob Ham et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Regulatory fog lifts on obesity drugs
Aaron Bouchie
NATURE BIOTECHNOLOGY (2012)
Metabolic syndrome meets osteoarthritis
Qi Zhuo et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Smart medication through combination of synthetic biology and cell microencapsulation
Simon Auslaender et al.
METABOLIC ENGINEERING (2012)
Lifestyle Change and Mobility in Obese Adults with Type 2 Diabetes
W. Jack Rejeski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity
L. J. Gray et al.
OBESITY REVIEWS (2012)
Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study
Arief Lalmohamed et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Current Updates in the Medical Management of Obesity
Areej Khan et al.
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY (2012)
Pramlintide and the treatment of diabetes: a review of the data since its introduction
Lisa M. Younk et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Obesity 2 Health and economic burden of the projected obesity trends in the USA and the UK
Y. Claire Wang et al.
LANCET (2011)
Structural basis for the assembly of the SMRT/NCoR core transcriptional repression machinery
Jasmeen Oberoi et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Synthetic Biology Moving into the Clinic
Warren C. Ruder et al.
SCIENCE (2011)
Lorcaserin: drug profile and illustrative model of the regulatory challenges of weight-loss drug development
Harold E. Bays
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2011)
Improvement of the monitoring and biosafety of encapsulated cells using the SFGNESTGL triple reporter system
Raul Catena et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Adjunct therapy for type 1 diabetes mellitus
Harold E. Lebovitz
NATURE REVIEWS ENDOCRINOLOGY (2010)
Pharmacological management of appetite expression in obesity
Jason C. G. Halford et al.
NATURE REVIEWS ENDOCRINOLOGY (2010)
Synthetic biology: applications come of age
Ahmad S. Khalil et al.
NATURE REVIEWS GENETICS (2010)
Controlling transgene expression in subcutaneous implants using a skin lotion containing the apple metabolite phloretin
Marc Gitzinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Protective effects of a topical antioxidant mixture containing vitamin C, ferulic acid, and phloretin against ultraviolet-induced photodamage in human skin
Christian Oresajo et al.
Journal of Cosmetic Dermatology (2008)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Medicare's search for effective obesity treatments - Diets are not the answer
Traci Mann et al.
AMERICAN PSYCHOLOGIST (2007)
Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus
Devada Singh-Franco et al.
CLINICAL THERAPEUTICS (2007)
Pharmacotherapy of obesity
K. G. Hofbauer et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2006)
Effector-repressor interactions, binding of a single effector molecule to the operator-bound TtgR homodimer mediates derepression
W Terán et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules
G Orive et al.
MOLECULAR THERAPY (2005)
Therapeutic applications of polymeric artificial cells
TMS Chang
NATURE REVIEWS DRUG DISCOVERY (2005)
History, challenges and perspectives of cell microencapsulation
G Orive et al.
TRENDS IN BIOTECHNOLOGY (2004)
Subtype specific effects of peroxisome proliferator-activated receptor ligands corepressor affinity
TB Stanley et al.
BIOCHEMISTRY (2003)
Emerging roles of PPARs in inflammation and immunity
RA Daynes et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Macrolide-based transgene control in mammalian cells and mice
W Weber et al.
NATURE BIOTECHNOLOGY (2002)
Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells
JL Simonsen et al.
NATURE BIOTECHNOLOGY (2002)
SAMY, a novel mammalian reporter gene derived from Bacillus stearothermophilus α-amylase
S Schlatter et al.
GENE (2002)
Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane
VF Duvivier-Kali et al.
DIABETES (2001)
PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
G Chinetti et al.
NATURE MEDICINE (2001)
Roles of PPARs in health and disease
S Kersten et al.
NATURE (2000)
The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes
RB Vega et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
